Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
Virginia Governor Glenn Youngkin named BIO’s…
WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and…
Learn more
New Season of “I am BIO” Podcast Explores Patient…
WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of…
Learn more
BIO Statement On Selected Drugs in Medicare under…
The Biotechnology Innovation Organization (BIO) released the following statement after today’s announcement from the Centers for Medicare & Medicaid Services (CMS) on selected drugs under the Inflation Reduction Act (IRA):“While the Inflation…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
Nonpartisan Budget Experts Warn Speaker Pelosi’s Drug Pricing Bill will Stifle the Development of New Medicines
October 14, 2019
BIO’s President and CEO Jim Greenwood issued the following statement after the Congressional Budget Office released an analysis confirming that H.R. 3 will lead to fewer new medicines for patients.
Biotechnology Innovation Organization Announces 2021 Leadership Transition
October 8, 2019
WASHINGTON – The Biotechnology Innovation Organization (BIO) today announced that industry veteran Jim Greenwood will step down as President and CEO of the world’s largest biotechnology organization after the 2020 election and help transition a new…
RFS Proposal Supports Green Energy Breakthroughs
October 4, 2019
The Biotechnology Innovation Organization (BIO) today released the following statement on the administration’s proposal on the Renewable Fuel Standard. The following statement may be attributed to Stephanie Batchelor, vice president of BIO's…
New Executive Order Critical to Protecting Patients and Public Health
September 20, 2019
President Trump has signed an executive order focused on spurring the development of new vaccine technologies, prioritizing the production of influenza vaccines and identifying strategies for communicating the importance of influenza vaccination…
Speaker Pelosi’s Drug Pricing Plan “Crushes the Desperate Hopes of Patients and their Families”
September 19, 2019
Washington, D.C. (September 19, 2019) – Former Congressman Jim Greenwood, the President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after Speaker Nancy Pelosi and Democratic leaders in the House of…
BIO Asia-Taiwan 2019 Showcased Biotech as the Region’s Next Growth Engine
August 29, 2019
Event Brought Together Biopharma Executives and Investors from Around the World for Deal Making and Partnering Opportunities
Administration Undermines Farmers and Rural Economies With Unjustifiable Renewable Fuel Standard Waivers
August 11, 2019
Washington, D.C. (August 10, 2019) –The Biotechnology Innovation Organization (BIO) released the following statement on the administration’s decision to issue 31 small refinery exemptions under the Renewable Fuel Standard. “The administration…
BIO Proposes Greater Public Access to Information on New Agricultural Biotechnology Products
August 5, 2019
The Biotechnology Innovation Organization (BIO) today put forward a consumer-friendly proposal that would improve public access to information about new agricultural biotechnology products. Combined with a new science-based regulatory approach, BIO…
HHS Drug Importation Plan a "Misguided Attempt to Keep an Ill-Informed Campaign Promise"
July 31, 2019
Following the introduction of the Trump administration’s drug importation proposal, BIO’s President and CEO Jim Greenwood issued the following statement: “There is simply no way to adopt an importation scheme that doesn’t jeopardize the health and…
Senate Finance Drug Pricing Proposal Misses the Mark
July 23, 2019
Washington, DC (July 23, 2019) – Following the release of the Senate Finance Committee’s drug pricing proposal, Tom DiLenge, the Biotechnology Innovation Organization’s President of Advocacy, Law & Public Policy Division issued the…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today